Evaluation of activated charcoal and lipid emulsion treatment in model of acute rivaroxaban toxicity
- 1 August 2018
- journal article
- research article
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 36 (8) , 1346-1349
Abstract
No abstract availableKeywords
Funding Information
- Ufuk University
This publication has 33 references indexed in Scilit:
- An Observational Study of the Factor Xa Inhibitors Rivaroxaban and Apixaban as Reported to Eight Poison CentersAnnals of Emergency Medicine, 2016
- Activated charcoal for acute overdose: a reappraisalBritish Journal of Clinical Pharmacology, 2015
- Parenteral emulsions and liposomes to treat drug overdoseAdvanced Drug Delivery Reviews, 2015
- Monitoring anticoagulant therapy with new oral agentsWorld Journal of Methodology, 2015
- Acute management of bleeding in patients on novel oral anticoagulantsEuropean Heart Journal, 2012
- Active Online Assessment of Patients Using New Oral Anticoagulants: Bleeding Risk, Compliance, and Coagulation AnalysisSeminars in Thrombosis and Hemostasis, 2012
- Determining the Optimal Dose of Intravenous Fat Emulsion for the Treatment of Severe Verapamil Toxicity in a Rodent ModelAcademic Emergency Medicine, 2008
- Injectable nanocarriers for biodetoxificationNature Nanotechnology, 2007
- Discovery of the Novel Antithrombotic Agent 5-Chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): An Oral, Direct Factor Xa InhibitorJournal of Medicinal Chemistry, 2005
- Gastrointestinal Clearance of Drugs with Activated CharcoalNew England Journal of Medicine, 1982